Answer
Serious infections such as sepsis or pneumonia, including fatal outcomes, have been reported in patients treated with Padcev (enfortumab vedotin).
Sources for this answer
- Padcev 20 mg and 30 mg powder for concentrate for solution for infusionAstellas Pharma Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 10Document updated
Sources checked